Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.902 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.865 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD7054 |
Approved |
0.8519 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8471 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8457 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8431 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8415 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8387 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8364 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8301 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8291 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8253 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8165 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8158 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8151 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8079 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8026 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7987 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7976 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD37 |
Approved |
0.7937 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7922 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7902 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7901 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7901 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7892 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7888 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7888 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7888 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7857 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7843 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7836 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7834 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.78 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7785 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7733 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7712 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7669 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7667 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7665 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7651 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7636 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD7240 |
Approved |
0.761 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7574 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7568 |
Intermediate Similarity |
NPD1203 |
Approved |
0.755 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7443 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.738 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7337 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7316 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7301 |
Intermediate Similarity |
NPD920 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.729 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7178 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7093 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7027 |
Intermediate Similarity |
NPD9545 |
Approved |
0.702 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7874 |
Approved |
0.6995 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6977 |
Remote Similarity |
NPD919 |
Approved |
0.6975 |
Remote Similarity |
NPD2800 |
Approved |
0.6975 |
Remote Similarity |
NPD2976 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD5535 |
Approved |
0.6962 |
Remote Similarity |
NPD4618 |
Approved |
0.6962 |
Remote Similarity |
NPD4622 |
Approved |
0.6957 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6948
|
Remote Similarity |
NPD1019 |
Discontinued |